NPIPB12

Chr 16

nuclear pore complex interacting protein family member B12

Based on the extremely limited information provided, I cannot write a clinically meaningful summary for NPIPB12. The data only indicates predicted membrane localization without any information about protein function, associated diseases, inheritance patterns, or clinical phenotypes that would be essential for a pediatric neurogenetics portal used by child neurologists.

ResearchSummary from RefSeq
Multiplemechanism

Population Genetics & Constraint

Constraint data not available from gnomAD.

DN
0.82top 10%
GOF
0.91top 5%
LOF
0.3941th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

NPIPB12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found